ACROBiosystems Co., Ltd. and Shanghai MediumBank Biotechnology Co., Ltd. (MediumBank) announced that the two companies have entered into a strategic cooperation centered on AI‑designed proteins developed by ACROBiosystems — beginning with thermostable bFGF and high‑activity cytokines — to systematically evaluate and industrialize computational protein design in cell culture media and biopharmaceutical processes.
Partnership Snapshot
| Item | Detail |
|---|---|
| Deal Type | Strategic cooperation agreement |
| Parties | ACROBiosystems Co., Ltd. & Shanghai MediumBank Biotechnology Co., Ltd. |
| Initial Focus | AI‑designed proteins – thermostable bFGF and high‑activity cytokines |
| Enabling Platform | ACROBiosystems’ ACRO AIx platform (computational protein design) |
| Iteration Model | “AI Design – Experimental Validation – Media Application – Data Feedback – Redesign” closed loop |
| Financial Terms | Not disclosed |
| Announcement Date | 15 Sep 2026 |
Collaboration Scope & Protein Portfolio
- Initial Assets: AI‑designed thermostable bFGF (basic fibroblast growth factor) and high‑activity cytokines — critical growth‑factor components widely used in cell culture media for biologics manufacturing and cell therapy processes.
- Application Testing: MediumBank will perform application testing and process validation across relevant culture media and culture systems, systematically evaluating how these AI proteins enhance media performance, improve cell culture outcomes, and optimize bioprocesses.
- Custom Co‑Development: Tailored to the practical needs of various culture media, cell systems, and biopharmaceutical processes, the two parties will jointly define performance targets for key proteins and custom‑develop AI proteins with superior stability, activity, or other critical performance attributes.
- Pipeline Breadth: Specific protein targets beyond bFGF and cytokines were not disclosed.
Division of Responsibilities & Closed‑Loop Workflow
- ACROBiosystems: Leverages its ACRO AIx platform for computational protein design, intelligent screening, expression, preparation, and preliminary quality evaluation.
- MediumBank: Completes application testing and process validation by integrating its culture media products, formulation development capabilities, cell culture processes, and customer application scenarios.
- Iterative Engine: Based on experimental data and application feedback, the companies will operate a closed‑loop process — “AI Design – Experimental Validation – Media Application – Data Feedback – Redesign” — accelerating the transition of AI proteins from design innovation to real‑world bioprocessing deployment.
Market Impact & Outlook
- AI Protein Design in Bioprocessing: Computational design of growth factors and cytokines is an emerging frontier in biologics manufacturing, where protein stability and potency directly influence media shelf life, batch consistency, and cost of goods for cell and gene therapies.
- Complementary Capabilities: The pairing joins ACROBiosystems’ AI‑driven design and protein production strengths with MediumBank’s media formulation and downstream application infrastructure — a vertically integrated path from in‑silico design to customer‑facing media products.
- Localization Angle: High‑performance recombinant growth factors have historically been dominated by overseas suppliers; an indigenously designed and validated AI protein portfolio supports supply‑chain localization for China’s bioprocessing sector.
- Next Catalysts: Validation readouts, jointly defined performance milestones, and commercialization plans remain not disclosed; timelines for the first co‑developed proteins have not been announced.
Forward‑Looking Statements
This brief contains forward‑looking statements regarding the strategic cooperation between ACROBiosystems and MediumBank, including the performance, validation outcomes, and commercialization potential of AI‑designed proteins. Actual results may differ materially due to risks including experimental validation outcomes, bioprocess scalability, regulatory requirements for media components, and competitive dynamics.-Fineline Info & Tech
